SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-011487
Filing Date
2017-05-02
Accepted
2017-05-02 17:46:37
Documents
2
Period of Report
2017-04-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6090
2 EX-24 DOCUMENT attachment1.htm EX-24 3822
  Complete submission text file 0000899243-17-011487.txt   11389
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Issuer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SPACELABS MEDICAL INC 15220 NE 40TH ST REDMOND WA 98053
Business Address
NUDELMAN PHILLIP M PHD (Reporting) CIK: 0001041084 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-28386 | Film No.: 17806420